Matilde Durán‐Lobato

860 citations
19 papers · 715 indexed · h-index 13

Matilde Durán‐Lobato

19 papers receiving 707 citations

Peers

Matilde Durán‐Lobato
Comparison fields: 5 of 95
  • Pharmaceutical Science 316
  • Biomaterials 233
  • Molecular Biology 230
  • Biomedical Engineering 139
  • Pharmacology 92
Replace M.R. Aberturas with:
M.R. Aberturas Spain
Hoang M. Trinh United States
Atul Jain India
Maria Bernadete Riemma Pierre Brazil
Gitu Pandey India
Hajar Ashrafi Iran
Christopher T. Rhodes United States
María Antonia Egea Spain
Elena Giuliano Italy
Morteza Azhdarzadeh Iran
Matilde Durán‐Lobato relative to M.R. Aberturas Spain M.R. Aberturas's profile →
Citations per field
00.5×4.5×
M.R. Aberturas · 1×
Citations per year

Countries citing papers authored by Matilde Durán‐Lobato

Since Specialization
Citations

This map shows the geographic impact of Matilde Durán‐Lobato's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Matilde Durán‐Lobato with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Matilde Durán‐Lobato more than expected).

Fields of papers citing papers by Matilde Durán‐Lobato

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Matilde Durán‐Lobato. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Matilde Durán‐Lobato. The network helps show where Matilde Durán‐Lobato may publish in the future.

Co-authorship network of co-authors of Matilde Durán‐Lobato

This figure shows the co-authorship network connecting the top 25 collaborators of Matilde Durán‐Lobato. A scholar is included among the top collaborators of Matilde Durán‐Lobato based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Matilde Durán‐Lobato. Matilde Durán‐Lobato is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

19 of 19 papers shown
#WorkIndexed citations
1 2
2 7
3 4
4 3
5 19
6 52
7 7
8 194
9 76
10 21
11 61
12 36
13 29
14 67
15 37
16 42
17 24
18 31
19 3

About Matilde Durán‐Lobato

Matilde Durán‐Lobato is a scholar working on Pharmaceutical Science, Pharmacology and Biomaterials, having authored 19 papers that have together received 715 indexed citations. Recurring topics across this work include Advanced Drug Delivery Systems (10 papers), Cannabis and Cannabinoid Research (6 papers) and Nanoparticle-Based Drug Delivery (4 papers). The work is most often cited by research in Pharmaceutical Science (316 citations), Biomaterials (233 citations) and Molecular Medicine (46 citations). Matilde Durán‐Lobato has collaborated with scholars based in Spain, Portugal and New Zealand. Frequent co-authors include Marı́a José Alonso, Zhigao Niu, Lucía Martín‐Banderas, Mercedes Fernández Arévalo, António J. Almeida, Lídia Gonçalves, Brenda Carrillo‐Conde, Nicholas A. Peppas, Josefa Álvarez‐Fuentes and M.A. Holgado. Their work appears in journals such as Advanced Materials, Advanced Drug Delivery Reviews and Scientific Reports.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026